NEW YORK (Reuters) - Merck & Co (NYSE:MRK - News), which has been hobbled by waning sales of several big medicines, gave a 2009 earnings and revenue outlook below Wall Street forecasts in large part because of the stronger dollar.
NEW YORK (Reuters) - Merck & Co (NYSE:MRK - News), which has been hobbled by waning sales of several big medicines, gave a 2009 earnings and revenue outlook below Wall Street forecasts in large part because of the stronger dollar.
